AEON Stock Summary and Trading Ideas (Aeon Biopharma Class A | AMEX:AEON)

AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.

Aeon Biopharma Class A trades on the AMEX stock market under the symbol AEON.

As of July 17, 2025, AEON stock price climbed to $0.79 with 111,310 million shares trading.

AEON has a beta of 2.88, meaning it tends to be more sensitive to market movements. AEON has a correlation of 0.03 to the broad based SPY ETF.

AEON has a market cap of $8.93 million. This is considered a Sub-Micro Cap stock.

The top ETF exchange traded funds that AEON belongs to (by Net Assets): VXF.

AEON has underperformed the market in the last year with a price return of -99.6% while the SPY ETF gained +12.5%. However, in the short term, AEON had mixed performance relative to the market. It has outperformed in the last 3 months, returning +97.5% vs +19.8% return in SPY. But in the last 2 weeks, AEON shares have been beat by the market, returning -6.0% compared to an SPY return of +1.3%.

AEON support price is $.72 and resistance is $.83 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AEON shares will trade within this expected range on the day.